The intensive care unit (ICU) provides highly complex medical care requiring precision, synchronization, and coordination of multiple services and personnel. Providing critical care consumes 30% of hospital expenses for just 8% of the hospital population. Currently, roughly 4.4 million Americans receive care in our ICUs annually, and it is estimated that this number will grow significantly as our population of Baby Boomers ages.
Among the most challenging aspects of this clinical setting is the necessity to avoid complications from ventilators and central lines, particularly ventilator-associated pneumonia (VAP) and catheter-related bloodstream infections.
VAP is a leading cause of morbidity and mortality in the ICU. Estimates are that VAP is associated with up to a 30% mortality rate — as high as 50% when the VAP is caused by a more virulent strain of infection.
VAP also increases length of stay in the hospital an average of 13 days, and brings an added cost per episode of $3,000 to $6,000.
Catheter-related bloodstream infections are also common complications in the ICU. Approximately 80,000 occur in intensive care units in the US alone each year.